<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Nepal</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Nepal.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/np.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Municipality-level spatial clustering and socio-environmental determinants of tuberculosis in Nepal, 2019–2024</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-14265-8-297fc0e5/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-14265-8-297fc0e5/</guid>
    <pubDate>Sat, 22 Aug 2026 00:00:00 GMT</pubDate>
    <description>The pronounced regional concentration of reported cases implies that precision resource deployment and area-specific prevention initiatives may better support national elimination objectives.</description>
    <category>Tuberculosis</category>
    <category>Climate and environment</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Evaluating the risk of dapsone hypersensitivity syndrome in Nepalese Leprosy Patients via HLA-B* 13:01 screening using real-time PCR and comparative meta-analysis of international data</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014568-d8a82d06/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014568-d8a82d06/</guid>
    <pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate>
    <description>Routine pre-therapy genetic assessment might lower the burden of severe medication-related complications in endemic regions with limited laboratory infrastructure.</description>
    <category>Leprosy</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Meta-analysis</category>
  </item>
  <item>
    <title>Azithromycin with or without cefixime for suspected or culture-confirmed uncomplicated typhoid fever in Nepal, Bangladesh, and Pakistan (ACT-South Asia): a double-blind, parallel-group, randomised, placebo-controlled, phase 4 trial</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-26-00358-0-b88ea3a1/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-26-00358-0-b88ea3a1/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings support the WHO recommendation of oral azithromycin monotherapy for uncomplicated typhoid fever and provide no evidence to justify adding cefixime, which has important antimicrobial stewardship implications given concerns about dual-drug resistance emergence.</description>
    <category>Typhoid fever</category>
    <category>COVID-19</category>
    <category>Dengue</category>
    <category>Malaria</category>
    <category>Typhus</category>
    <category>Scrub Typhus</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Effectiveness of the TYPHIBEV® (Vi-CRM197 conjugate) vaccine introduction in Nepal: A test-negative, case-control study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106719-705b2901/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106719-705b2901/</guid>
    <pubDate>Wed, 01 Apr 2026 00:00:00 GMT</pubDate>
    <description>The documented high protection rate suggests utility for national immunization programs aiming to reduce severe bacterial enteric disease in endemic regions.</description>
    <category>Typhoid fever</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Treatment</category>
    <category>Surveillance</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>A Large Outbreak of Salmonella Paratyphi A Infection Among Israeli Travelers To Nepal</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-cit723-b312034a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-cit723-b312034a/</guid>
    <pubDate>Tue, 05 Nov 2013 00:00:00 GMT</pubDate>
    <description>The outbreak highlights the risk of paratyphoid fever among travelers to endemic areas in Asia and suggests that combination antibiotic therapy may improve clinical outcomes. The point-source nature and nalidixic acid resistance pattern have implications for travel medicine and outbreak response.</description>
    <category>Paratyphoid fever</category>
    <category>Treatment</category>
    <category>Travel medicine</category>
    <category>Outbreak investigation</category>
    <category>Outbreak investigation</category>
  </item>
</channel>
</rss>
